why choose us

First received: October 20, 2023

Clinical Trial: Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Head and Neck Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase I Study of Xevinapant With Radiation and Concurrent Carboplatin and Paclitaxel in Patients Ineligible for Cisplatin With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck

Brief Summary: The goal of this clinical trial is to determine the best safe dose of xevinapant that can be given in combination with chemotherapy and radiation in patients with head and neck cancer.Up to 4 doses of xevinapant will be tested in the dose escalation portion of the study.After the best safe dose is found during escalation, an additional group of participants will be enrolled at that dose to learn more about the treatment combination (dose expansion).The main question[s] it aims to answer are:what is the maximum…

Read more